DCC Recommends Issuance Of Advisory To SLAs For Monitoring Quality Of Eye Drops In Packages

New Delhi: The Drugs Consultative Committee (DCC) has recommended to the national drug regulatory authority to issue an advisory to the State Licensing Authorities to monitor the quality of eye drops in packages, in a move to address the issues related to particulate matter and contamination in these products.

Based on a recommendation by the Committee in the previous meeting, a consultation meeting was conducted with industry associations and industry members to check whether these formulations can be packed in transparent plastic vials or bottles.

The Committee was considering a proposal to amend the Drugs Rules, 1945 with respect to the packing of eye drops in opaque plastic vials or bottles by the pharmaceutical companies.

Following the consultation meeting, the Committee in its 64th meeting held on June 19, 2024, said, “After detailed deliberation, the committee recommended that an advisory may be issued to the SLA’s for monitoring the quality of such products.”

In a DCC meeting held in June, 2023, the issue was discussed on the basis of historical testing results of eye drops sampling which showed that most of the samples failed in description due to particulate matter and contamination.

The Committee, during the time, requested to ensure that eye drop formulations are packed in transparent plastic vials/bottles, so that the consumer can ensure the clarity of eye drop before instilling.

Related Posts

  • Pharma
  • February 10, 2025
  • 92 views
DGFT Amends Standard Input Output Norms For Erythromycin Stearate Tablets

Mumbai:  The Directorate General of Foreign Trade (DGFT), under the ministry of commerce & industry, has announced amendments to the Standard Input Output Norms (SION) for the export of erythromycin…

  • Pharma
  • February 10, 2025
  • 96 views
CSIR-NIIST Develops Technology To Convert Biomedical Waste Into Soil Additives

THIRUVANANTHAPURAM: CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) in Thiruvananthapuram has developed a technology that converts pathogenic biomedical waste into value-added soil additives that eliminate the need for costly…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

An Index To Gauge States For Drug Enforcement, Improve Drug Quality

An Index To Gauge States For Drug Enforcement, Improve Drug Quality

DGFT Amends Standard Input Output Norms For Erythromycin Stearate Tablets

DGFT Amends Standard Input Output Norms For Erythromycin Stearate Tablets

CSIR-NIIST Develops Technology To Convert Biomedical Waste Into Soil Additives

CSIR-NIIST Develops Technology To Convert Biomedical Waste Into Soil Additives

As Always Ahead of Game in healthcare, Doc was first to vote too

As Always Ahead of Game in healthcare, Doc was first to vote too

Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister